According to CTI BioPharma
's latest financial reports the company has -$25.35 M in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2022-12-31 | $-17.58 M | -566.6% |
2021-12-31 | $3.76 M | -90.59% |
2020-12-31 | $40.02 M | 123.25% |
2019-12-31 | $17.93 M | -66.13% |
2018-12-31 | $52.93 M | 229.02% |
2017-12-31 | $16.09 M | 107.43% |
2016-12-31 | $7.75 M | -83.64% |
2015-12-31 | $47.41 M | 23.22% |
2014-12-31 | $38.47 M | -10.01% |
2013-12-31 | $42.75 M | 29.79% |
2012-12-31 | $32.94 M | 17.62% |
2011-12-31 | $28 M | -644.39% |
2010-12-31 | $-5.15 M | -72.59% |
2009-12-31 | $-18.77 M | -84.82% |
2008-12-31 | $-0.13 B | 14.62% |
2007-12-31 | $-0.11 B | 6.19% |
2006-12-31 | $-0.11 B | -5.13% |
2005-12-31 | $-0.11 B | 51.46% |
2004-12-31 | $-70.71 M | -14.34% |
2003-12-31 | $-82.55 M | -289.83% |
2002-12-31 | $43.48 M | -60.31% |
2001-12-31 | $0.10 B |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Novartis NVS | $46.75 B | -184,539.97% | ๐จ๐ญ Switzerland |
Eli Lilly LLY | $10.86 B | -42,959.90% | ๐บ๐ธ USA |
Amgen AMGN | $6.23 B | -24,686.74% | ๐บ๐ธ USA |
Baxter BAX | $8.46 B | -33,508.29% | ๐บ๐ธ USA |
Incyte INCY | $5.18 B | -20,575.16% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $29.48 B | -116,425.40% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $8.12 B | -32,159.02% | ๐ฎ๐ฑ Israel |